Research for maternal inflammatory status and epidural-related maternal fever: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023966

Enrollment

Unknown

Registered

2019-06-19

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epidural-related maternal fever

Interventions

Group C1:The analgesia protocol is background continuous infusion combined with PCA bolus, with 0.1% ropivacaine

Group C2:The analgesia protocol is background continuous infusion combined with PCA bolus, with 0.075% ropivacaine

Group I:The analgesia protocol is programmed intermittent epidural bolus combined with PCA bolus, with 0.1% ropivacaine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Parturients who volunteer to accept epidural analgesia.

Exclusion criteria

Exclusion criteria: Known infection(systemic or local,such as GBS+), PROM, GDM, current antibiotic prescription or taking other medicine which may influence temperature such as NSAIDs.

Design outcomes

Primary

Measure	Time frame
ear temperature;Blood IL-6;Blood IL-1;umbilical vein blood gas;	—

Countries

China

Contacts

Public ContactZhang Yueqi

Shanghai First Materniy and Infant Hospital

zyq0356232@126.com+86 13917382427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026